Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analgesic nephropathy.

R S Nanra

    The Medical Journal of Australia
    |May 15, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Analgesic nephropathy, linked to high intake of pain relievers like aspirin, can cause kidney damage. Avoiding these drugs is key for managing kidney function and preventing further harm.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationship between nonphenacetin-combined analgesics and nephropathy.

    Kidney international·2001
    Same author

    The renal medulla in acute renal allograft rejection: comparison with renal cortex.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1995
    Same author

    The hypo-echoic cortical rim in lupus nephritis.

    Australasian radiology·1994
    Same author

    Eosinophils in acute renal allograft rejection.

    Transplant immunology·1994
    Same author

    Analgesic nephropathy in the 1990s--an Australian perspective.

    Kidney international. Supplement·1993
    Same author

    Pattern of renal dysfunction in analgesic nephropathy--comparison with glomerulonephritis.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1992
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    Same journal

    Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

    The Medical journal of Australia·2026
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Toxicology
    • Gerontology

    Background:

    • Analgesic nephropathy is associated with chronic abuse of combination analgesics (APC).
    • Ischemic heart disease and premature aging are emerging aspects of this syndrome.
    • Renal papillary necrosis, diagnosed radiologically, is a hallmark of analgesic nephropathy.

    Purpose of the Study:

    • To highlight the clinical syndrome associated with analgesic abuse.
    • To identify key diagnostic features and management strategies for analgesic nephropathy.
    • To elucidate the specific nephrotoxic roles of aspirin, phenacetin, and paracetamol.

    Main Methods:

    • Review of clinical data and radiological findings in patients with analgesic nephropathy.
    • Analysis of the nephrotoxic contributions of individual components in APC mixtures.

    Related Experiment Videos

    Main Results:

    • A minimum intake of 2 kg of aspirin or phenacetin is linked to analgesic nephropathy.
    • Aspirin is identified as the primary nephrotoxic agent in APC mixtures.
    • Phenacetin and paracetamol play a secondary, synergistic role in nephrotoxicity.

    Conclusions:

    • Total avoidance of non-steroid anti-inflammatory agents is crucial for managing established analgesic nephropathy and renal insufficiency.
    • Cessation of offending analgesics often leads to stabilization or improvement in renal function.
    • Understanding the specific roles of aspirin, phenacetin, and paracetamol aids in preventing and managing analgesic-induced kidney disease.